Many post-op patients use medications to help with weight regain, appetite control, or metabolic issues
The unprecedented clinical efficacy, demonstrated by universal response rates and significant weight reduction outcomes, positions this API at the forefront of pharmaceutical innovation
Studies using magnetic resonance imaging and liver biopsy have shown significant reductions in hepatic steatosis with GLP-1 receptor agonist therapy
Medication, dosing, nutrition, and symptom decisions should be made with your doctor or licensed clinician
Understanding the nuances of insulin adjustments and risk management is crucial for optimizing treatment outcomes for individuals with Type 1 Diabetes.
Fontana L, Weiss EP, Villareal DT, Klein S, Holloszy JO, Holloszy O